MF · holdings as filed 2026-04-30

What's inside BBP?

Virtus Biotech Etf
Holdings
62
positions in the fund
Top 10
26%
of fund assets
Expense ratio
0.34%
net, per year
Fund size
$59M
total net assets
Sectors
Top holdings — Health Care
Your 10 largest positions in this sector
1
I
IBRXIMMUNITYBIO INC
4.68%
2
M
MRNAMODERNA INC
2.42%
3
I
IOVAIOVANCE BIOTHERAPEUTICS INC
2.37%
4
M
MIRMMIRUM PHARMACEUTICALS INC
2.33%
5
A
AXSMAXSOME THERAPEUTICS INC
2.18%
6
K
KNSAKINIKSA PHARMACEUTICALS INTE
2.01%
7
R
ROIVROIVANT SCIENCES LTD
2.01%
8
Z
ZLABZAI LAB LTD-ADR
1.89%
9
L
LGNDLIGAND PHARMACEUTICALS
1.88%
10
B
BCRXBIOCRYST PHARMACEUTICALS INC
1.88%
Geography
Top holdings — United States
Your 10 largest positions in this country
1
I
IBRXIMMUNITYBIO INC
4.68%
2
M
MRNAMODERNA INC
2.42%
3
I
IOVAIOVANCE BIOTHERAPEUTICS INC
2.37%
4
M
MIRMMIRUM PHARMACEUTICALS INC
2.33%
5
A
AXSMAXSOME THERAPEUTICS INC
2.18%
6
L
LGNDLIGAND PHARMACEUTICALS
1.88%
7
B
BCRXBIOCRYST PHARMACEUTICALS INC
1.88%
8
T
TVTXTRAVERE THERAPEUTICS INC
1.88%
9
N
NVAXNOVAVAX INC
1.88%
10
U
UTHRUNITED THERAPEUTICS CORP
1.80%
Geography reflects each issuer's registered business address per SEC EDGAR filings where available, falling back to the exchange or listing where no SEC filing exists — not necessarily where a company's stock is primarily listed (e.g. TSMC is classified as Taiwan even though its ADR trades on the NYSE).
Hold BBP alongside other funds? See your combined true holdings, overlap, and blended fees — free, no signup.
Unwrap your portfolio →
Data source: official SEC Form N-PORT filings (as of 2026-04-30); expense ratio from SEC prospectus (risk/return) filings. Fund holdings are disclosed quarterly and may reflect a 60-day reporting delay.
Informational and educational only — not investment advice.